Altamira Therapeutics’s (CYTOF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Altamira Therapeutics is a Buy.
Altamira Therapeutics’s (CYTOF) 20-Day exponential moving average is $0.08, while Altamira Therapeutics’s (CYTOF) share price is $0.07, making it a Sell.
Altamira Therapeutics’s (CYTOF) 50-Day exponential moving average is $0.08, while Altamira Therapeutics’s (CYTOF) share price is $0.07, making it a Sell.
Altamira Therapeutics’s (CYTOF) 10-Day exponential moving average is $0.08, while Altamira Therapeutics’s (CYTOF) share price is $0.07, making it a Sell.
Altamira Therapeutics’s (CYTOF) 100-Day exponential moving average is $0.08, while Altamira Therapeutics’s (CYTOF) share price is $0.07, making it a Sell.
Altamira Therapeutics’s (CYTOF) stock price is $0.07 and Altamira Therapeutics’s (CYTOF) 50-day simple moving average is $0.08, creating a Sell signal.
Altamira Therapeutics’s (CYTOF) stock price is $0.07 and Altamira Therapeutics’s (CYTOF) 100-day simple moving average is $0.07, creating a Sell signal.
Altamira Therapeutics’s (CYTOF) stock price is $0.07 and Altamira Therapeutics’s (CYTOF) 200-day simple moving average is $0.08, creating a Sell signal.